Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$128M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$32.6M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$28.6M |
| 4 |
Tyler Technologies
TYL
|
+$26.9M |
| 5 |
Brown & Brown
BRO
|
+$19.5M |
Top Sells
| 1 |
Apple
AAPL
|
+$284M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Alibaba
BABA
|
+$158M |
| 5 |
Amazon
AMZN
|
+$104M |
Sector Composition
| 1 | Technology | 21.52% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.17% |
| 5 | Industrials | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Astronics
ATRO
$1.41B
| $1.32M | ﹤0.01% |
47,355
+1,300
| +3% | +$36.3K |
|
|
NWLI
1977
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.32M | ﹤0.01% |
4,549
| – | – |
|
|
SAVE
1978
DELISTED
Spirit Airlines, Inc.
SAVE
| $1.32M | ﹤0.01% |
32,800
+1,000
| +3% | +$40.3K |
|
1979
Pitney Bowes
PBI
$1.96B
| $1.32M | ﹤0.01% |
327,100
-11,900
| -4% | -$47.9K |
|
1980
RE/MAX Holdings
RMAX
$195M
| $1.32M | ﹤0.01% |
34,200
+1,100
| +3% | +$42.3K |
|
|
AEGN
1981
DELISTED
Aegion Corp
AEGN
| $1.32M | ﹤0.01% |
58,800
| – | – |
|
1982
Gorman-Rupp
GRC
$1.13B
| $1.31M | ﹤0.01% |
34,947
+1,000
| +3% | +$37.5K |
|
1983
Rhythm Pharmaceuticals
RYTM
$6.39B
| $1.31M | ﹤0.01% |
57,100
+21,900
| +62% | +$503K |
|
1984
Amphastar Pharmaceuticals
AMPH
$1.3B
| $1.31M | ﹤0.01% |
67,800
+1,600
| +2% | +$30.9K |
|
1985
Evolent Health
EVH
$1.05B
| $1.31M | ﹤0.01% |
144,500
+5,900
| +4% | +$53.4K |
|
1986
Peoples Bancorp
PEBO
$1.08B
| $1.3M | ﹤0.01% |
37,600
+800
| +2% | +$27.7K |
|
|
WPG
1987
DELISTED
Washington Prime Group Inc.
WPG
| $1.3M | ﹤0.01% |
39,685
+1,211
| +3% | +$39.7K |
|
|
BORR
1988
Borr Drilling
BORR
$862M
| $1.3M | ﹤0.01% |
75,226
+5,851
| +8% | +$101K |
|
|
GOOD
1989
Gladstone Commercial Corp
GOOD
$608M
| $1.3M | ﹤0.01% |
59,300
+2,400
| +4% | +$52.5K |
|
1990
Barrett Business Services
BBSI
$1.2B
| $1.29M | ﹤0.01% |
57,200
+1,600
| +3% | +$36.2K |
|
|
TVRD
1991
Tvardi Therapeutics, Inc. Common Stock
TVRD
$318M
| $1.29M | ﹤0.01% |
2,228
+103
| +5% | +$59.7K |
|
|
TEN
1992
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $1.29M | ﹤0.01% |
98,300
+2,700
| +3% | +$35.4K |
|
1993
FB Financial Corp
FBK
$2.86B
| $1.29M | ﹤0.01% |
32,500
+1,100
| +4% | +$43.6K |
|
|
WLL
1994
DELISTED
Whiting Petroleum Corporation
WLL
| $1.28M | ﹤0.01% |
2,331
+68
| +3% | +$37.4K |
|
|
QTNT
1995
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $1.28M | ﹤0.01% |
3,370
+885
| +36% | +$337K |
|
|
FLXN
1996
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.28M | ﹤0.01% |
61,911
+2,000
| +3% | +$41.4K |
|
1997
Pacific Biosciences
PACB
$351M
| $1.28M | ﹤0.01% |
248,846
+5,200
| +2% | +$26.7K |
|
1998
Origin Bancorp
OBK
$1.11B
| $1.28M | ﹤0.01% |
33,682
+500
| +2% | +$18.9K |
|
1999
DXP Enterprises
DXPE
$1.85B
| $1.27M | ﹤0.01% |
32,000
+1,000
| +3% | +$39.8K |
|
2000
Nicolet Bankshares
NIC
$2B
| $1.27M | ﹤0.01% |
17,200
+1,300
| +8% | +$96K |
|